Rest R F, Liu J, Talukdar R, Frangipane J V, Simon D
Department of Microbiology and Immunology, Hahnemann University School of Medicine, Philadelphia, Pennsylvania 19102-1192.
Ann N Y Acad Sci. 1994 Aug 15;730:182-96. doi: 10.1111/j.1749-6632.1994.tb44248.x.
N. gonorrhoeae initiates infection by adhering to and invading columnar epithelial cells. Over time these activities often induce inflammation, with the influx of neutrophils and serum into the urethral lumen, cervical os, conjunctiva, and the like. At least some of these infected niches contain CMP-NANA (cytidine monophospho-N-acetyl neuraminic acid, also called CMP-sialic), contain sialylated gonococci, and are relatively or strictly anaerobic due to neutrophil and gonococcal metabolism and to the site of disease, that is, the peritoneal cavity. Gonococci thus encounter environmental conditions, reagents, and substrates in the human body that are not normally present in vitro. Knapp and Clark were the first to successfully grow gonococci anaerobically in an easily reproducible system, allowing researchers to begin to investigate in vitro the effects of anaerobiosis on gonococcal virulence traits. As a result of a series of elegant and in depth studies, Smith and Parsons and their colleagues showed that growth in CMP-NANA confers on the gonococcus a high degree of phenotypic (readily reversible) serum resistance and that CMP-NANA is available in vivo at sites of gonococcal infection and disease; gonococci become covalently coated with sialic acid and they become serum resistant (reviewed in refs. 8-10). Given that gonococci growing in the absence of oxygen or in the presence of CMP-NANA probably more closely resemble gonococci growing inside the human host, we studied several possible virulence traits of gonococci cultivated under these conditions. We first observed that anaerobic growth (in the absence of CMP-NANA) increases gonococcal resistance to killing by low (but not high) concentrations of normal human serum. We also asked whether anaerobic growth affected gonococcal association with host cells. Contrary to the effects on serum killing, anaerobic growth (in the absence of CMP-NANA) does not appear to affect the ability of gonococci (expressing certain adhesive outer membrane proteins called Opa proteins) to bind to and enter human epithelial cell lines or to bind to or resist killing by human neutrophils. The results from studies investigating the modulatory role of CMP-NANA were more striking. Growth in CMP-NANA dramatically inhibits the adherence of Opa+ gonococci to human neutrophils. It does not, however, appear to significantly decrease their sensitivity to phagocytic killing or to in vitro killing by lysosomal contents (aqueous extracts of human neutrophil granules).(ABSTRACT TRUNCATED AT 400 WORDS)
淋病奈瑟菌通过黏附并侵入柱状上皮细胞引发感染。随着时间推移,这些活动常常会诱发炎症,中性粒细胞和血清会流入尿道腔、宫颈口、结膜等部位。至少部分这些受感染的微环境含有CMP-NANA(胞苷单磷酸-N-乙酰神经氨酸,也称为CMP-唾液酸),含有唾液酸化的淋球菌,并且由于中性粒细胞和淋球菌的代谢以及疾病发生部位(即腹腔)的原因,相对或严格处于厌氧状态。因此,淋球菌会遇到人体中通常在体外不存在的环境条件、试剂和底物。克纳普和克拉克率先在一个易于重现的系统中成功实现淋球菌的厌氧培养,这使得研究人员能够开始在体外研究厌氧状态对淋球菌毒力特性的影响。经过一系列精妙且深入的研究,史密斯和帕森斯及其同事表明,在CMP-NANA中生长赋予淋球菌高度的表型(易于逆转)血清抗性,并且CMP-NANA在淋球菌感染和疾病发生部位的体内是可获取的;淋球菌会被唾液酸共价包被,进而获得血清抗性(参考文献8 - 10中有综述)。鉴于在无氧或存在CMP-NANA条件下生长的淋球菌可能更类似于在人体宿主内生长的淋球菌,我们研究了在这些条件下培养的淋球菌的几种可能的毒力特性。我们首先观察到厌氧生长(在不存在CMP-NANA的情况下)会增加淋球菌对低浓度(但不是高浓度)正常人血清杀伤作用的抗性。我们还研究了厌氧生长是否会影响淋球菌与宿主细胞的结合。与对血清杀伤作用的影响相反,厌氧生长(在不存在CMP-NANA的情况下)似乎不会影响淋球菌(表达某些称为Opa蛋白的黏附性外膜蛋白)与人类上皮细胞系结合并进入细胞的能力,也不会影响其与人类中性粒细胞结合或抵抗中性粒细胞杀伤的能力。研究CMP-NANA调节作用的结果更为显著。在CMP-NANA中生长会显著抑制Opa +淋球菌与人类中性粒细胞的黏附。然而似乎并不会显著降低它们对吞噬杀伤作用或对溶酶体内容物(人类中性粒细胞颗粒的水提取物)体外杀伤作用的敏感性。(摘要截选至400词)